New tool aims to empower moms after hypertensive pregnancy
NCT ID NCT06996496
First seen Jun 26, 2026 · Last updated Sep 18, 2026 · Updated 2 times
Summary
This study tests whether a simple educational guide can help postpartum patients who had high blood pressure during pregnancy become more active in their own care. Researchers will give the tool to some mothers shortly after delivery and compare their engagement scores with those who did not receive it. The goal is to see if the tool improves how patients manage their health in the weeks after birth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- postpartum educational tool
- What this could lead to
- If successful, this tool could help new mothers with high blood pressure better manage their health after pregnancy.
- What could go wrong
- This is a small, early-stage implementation study, not a treatment trial. The tool may not significantly change patient behavior or outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
150 people
The number who actually took part.
- Started
-
Sep 2024
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Inclusion criteria: * clinical diagnosis of a hypertensive disorder of pregnancy, defined as having blood pressure reading greater than 130/80 * be postpartum * 18 or older at the time of enrollment * able to speak, read, and understand English or Spanish. Patient Exclusion criteria: * no clinical diagnosis of hypertension before, during, or after their pregnancy defined as having blood pressure reading greater than 130/80 * under the age of 18 * only able to speak and read in a language other than English or Spanish * unable to legally consent to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertension, pregnancy induced are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two proteins could give african clinics an early warning for dangerous pregnancy complication
- Can a simple tape measure make blood pressure readings more accurate in pregnancy?
- Can a climate-smart pregnancy care program prevent stillbirths in a fast-growing city?
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- New decision aid aims to cut heart disease risk in women after complicated pregnancies
- Could cocoa and veggies protect against pregnancy complications?